PET/X Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 4


  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $1.97M

  • Investors
  • 5

PET/X General Information


Developer of breast cancer diagnosis system designed to detect cancer and avoid delays. The company combines positron emission tomography and X-ray mammography to determine which targeted breast cancer therapies will be effective for each patient, enabling physicians to offer targeted treatment for cancer and improve patient health.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Corporate Office
  • 4000 Mason Road
  • Suite 300
  • Seattle, WA 98195
  • United States
+1 (855) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PET/X Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant 01-Jan-2020 $1.97M Completed Startup
5. Grant 01-Jan-2017 00000 Completed Startup
4. Grant 29-Sep-2016 00000 Completed Startup
3. Grant 01-Jan-2013 00000 Completed Startup
2. Accelerator/Incubator Completed Startup
1. Spin-Off 01-Jan-2012 Completed Startup
To view PET/X’s complete valuation and funding history, request access »

PET/X Executive Team (3)

Name Title Board Seat Contact Info
William Hunter Ph.D Chief Executive Officer & Chief Scientific Officer
Lawrence Macdonald Ph.D Co-Founder
Paul Kinahan Ph.D Co-Founder
To view PET/X’s complete executive team members history, request access »

PET/X Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PET/X Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Cancer Institute Government 000 0000 000000 0
National institutes of Neurological Disorders and Stroke Government 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
University of Washington University 000 0000 000000 0
UW CoMotion Labs Accelerator/Incubator 000 0000 000000 0
To view PET/X’s complete investors history, request access »


  • When was PET/X founded?

    PET/X was founded in 2012.

  • Who is the founder of PET/X?

    Lawrence Macdonald Ph.D and Paul Kinahan Ph.D are the founders of PET/X.

  • Who is the CEO of PET/X?

    William Hunter Ph.D is the CEO of PET/X.

  • Where is PET/X headquartered?

    PET/X is headquartered in Seattle, WA.

  • What is the size of PET/X?

    PET/X has 4 total employees.

  • What industry is PET/X in?

    PET/X’s primary industry is Diagnostic Equipment.

  • Is PET/X a private or public company?

    PET/X is a Private company.

  • What is PET/X’s current revenue?

    The current revenue for PET/X is 00000.

  • Who are PET/X’s investors?

    National Cancer Institute, National institutes of Neurological Disorders and Stroke, National Institutes of Health, University of Washington, and UW CoMotion Labs have invested in PET/X.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »